Kindred Biosciences, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (18)

Latest Posts

About This Stock More About This Stock
Four Best Biotech Stocks Of The First Quarter Of 2016
Article By: Zacks Investment Research
Sunday, April 3, 2016 7:19 AM EDT
The entry of the first FDA-approved biosimilar, Zarxio, a biosimilar version of Amgen’s blockbuster drug, Neupogent, last year has left biotech companies vying to enter this high revenue generating space. Biosimilars are the next big thing.
In this article: KIN, CRMD, ALIOF, MESO Also: AMGN, GILD, SHPG, BXLT

Latest Tweets for $KIN

No tweets yet!



Four Best Biotech Stocks of the First Quarter of 2016
David J. Tanner 5/3/2018 2:55:32 AM

Would like to see more on $KIN, thanks.

1 to 1 of 1 comments